Results 21 to 30 of about 5,109,346 (334)

Pancreatic cancer

open access: bronzeSurgical Clinics of North America, 1975
Masahiro Shin, Tsutomu TAKASHIMA
openalex   +4 more sources

Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas

open access: yesWorld Journal of Surgical Oncology, 2022
Background Intraductal papillary mucinous neoplasms (IPMNs) are characterized by their abundant mucin production and malignant potential. IPMNs of the pancreas are mainly managed according to their radiographic indications, but this approach lacks ...
Yunzhen Qian   +12 more
doaj   +1 more source

Pancreatic Cancer [PDF]

open access: goldCA: A Cancer Journal for Clinicians, 1982
B. I. Loigman
openalex   +3 more sources

Pancreatic Cancer: A Review of Current Treatment and Novel Therapies.

open access: yesJournal of investigative surgery, 2022
Pancreatic cancer is one of the leading causes for cancer-related deaths in the United States. Majority of patients present with unresectable or metastatic disease.
H. Kolbeinsson   +3 more
semanticscholar   +1 more source

Pancreatic cancer [PDF]

open access: yesCA: A Cancer Journal for Clinicians, 1994
Pancreatic cancer is a devastating disease for the patient and presents challenging diagnostic and management problems for the physician. A range of serologic and radiologic studies are available for evaluation and staging of this disease. However, invasive studies, including laparotomy, are often necessary to establish the diagnosis and resectability.
Michel G. Sarr   +3 more
openaire   +3 more sources

Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy

open access: yesCancer Control, 2020
Lymphatic metastasis is a major determinant of the outcome of resected pancreatic cancer. Gemcitabine-based adjuvant chemotherapy can improve the outcome of resected pancreatic cancer.
Chen Liu MD, PhD   +10 more
doaj   +1 more source

Pancreatic cancer: A review of epidemiology, trend, and risk factors

open access: yesWorld Journal of Gastroenterology, 2021
Despite rapid advances in modern medical technology and significant improvements in survival rates of many cancers, pancreatic cancer is still a highly lethal gastrointestinal cancer with a low 5-year survival rate and difficulty in early detection.
Jiannan Hu   +6 more
semanticscholar   +1 more source

Targeting hypoxic tumor microenvironment in pancreatic cancer

open access: yesJournal of Hematology & Oncology, 2021
Attributable to its late diagnosis, early metastasis, and poor prognosis, pancreatic cancer remains one of the most lethal diseases worldwide. Unlike other solid tumors, pancreatic cancer harbors ample stromal cells and abundant extracellular matrix but ...
Jinxin Tao   +10 more
semanticscholar   +1 more source

Pancreatic Cancer [PDF]

open access: yesAnnual Review of Pathology: Mechanisms of Disease, 2007
The past two decades have witnessed an explosion in our understanding of pancreatic cancer, and it is now clear that pancreatic cancer is a disease of inherited (germ-line) and somatic gene mutations. The genes mutated in pancreatic cancer include KRAS2, p16/CDKN2A, TP53, and SMAD4/DPC4, and these are accompanied by a substantial compendium of genomic ...
Anirban, Maitra, Ralph H, Hruban
openaire   +2 more sources

Pancreatitis and Pancreatic Cancer Risk

open access: yesTechnology in Cancer Research & Treatment, 2023
Purpose: The present retrospective study aimed to explore the relationship between pancreatitis and pancreatic cancer in the population cohort of the UK Biobank (UKB) ( https://www.ukbiobank.ac.uk ). Methods: From the 500 thousand population cohort of UKB, according to the age and gender of patients with pancreatic cancer 1:10, matching the control ...
Dong-Mei Ma   +6 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy